Lymphocyte depletion and subset alteration correlate to renal function in chronic kidney disease patients

Renal Failure

Volumn 38, Issue 1, 2016, Pages 7-14

  Xiang, Fang Fang ^a   Zhu, Jia Ming ^b   Cao, Xue Sen ^a   Shen, Bo ^a   Zou, Jian Zhou ^a   Liu, Zhong Hua ^a   Zhang, Hao ^a   Teng, Jie ^a   Liu, Hong ^b   Ding, Xiao Qiang ^a  

^a FUDAN UNIVERSITY   (China)

^b Kidney and Dialysis Institute of Shanghai   (China)

Author keywords

B cell; chronic kidney disease; lymphocyte subsets; natural killer cell; renal clearance

Indexed keywords

ADULT; ARTICLE; B LYMPHOCYTE; CHRONIC KIDNEY DISEASE; CROSS-SECTIONAL STUDY; FEMALE; FLOW CYTOMETRY; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; KIDNEY FUNCTION; LYMPHOCYTE DEPLETION; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; AGED; CHRONIC KIDNEY FAILURE; IMMUNOLOGY; KIDNEY FUNCTION TEST; MIDDLE AGED;

ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY FUNCTION TESTS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC;

EID: 84955748941     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2015.1106871     Document Type: Article

References (61)

1. Wen CP, Cheng TY, Tsai MK, et al. All-cause mortality attributable to chronic kidney disease: A prospective cohort study based on 462 293 adults in Taiwan. Lancet. 2008; 371: 2173-2182
2. Drey N, Roderick P, Mullee M, Rogerson M. A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am J Kidney Dis. 2003; 42: 677-684
3. Tonelli M, Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: A systematic review. J Am Soc Nephrol. 2006; 17: 2034-2047
4. Gollapudi P, Yoon JW, Gollapudi S, et al. Leukocyte toll-like receptor expression in end-stage kidney disease. Am J Nephrol. 2010; 31: 247-254
5. Koc M, Toprak A, Arikan H, et al. Toll-like receptor expression in monocytes in patients with chronic kidney disease and haemodialysis: Relation with inflammation. Nephrol Dial Transplant. 2011; 26: 955-963
6. Yoon JW, Pahl MV, Vaziri ND. Spontaneous leukocyte activation and oxygen-free radical generation in end-stage renal disease. Kidney Int. 2007; 71: 167-172
7. Alexiewicz JM, Smogorzewski M, Fadda GZ, Massry SG. Impaired phagocytosis in dialysis patients: Studies on mechanisms. Am J Nephrol. 1991; 11: 102-111
8. Massry S, Smogorzewski M. Dysfunction of polymorphonuclear leukocytes in uremia: Role of parathyroid hormone. Kidney Int Suppl. 2001; 78: S195-S196
9. Agrawal S, Gollapudi P, Elahimehr R, et al. Effects of end-stage renal disease and haemodialysis on dendritic cell subsets and basal and LPS-stimulated cytokine production. Nephrol Dial Transplant. 2010; 25: 737-746
10. Hesselink DA, Betjes MG, Verkade MA, et al. The effects of chronic kidney disease and renal replacement therapy on circulating dendritic cells. Nephrol Dial Transplant. 2005; 20: 1868-1873
11. Verkade MA, van Druningen CJ, Vaessen LM, et al. Functional impairment of monocyte-derived dendritic cells in patients with severe chronic kidney disease. Nephrol Dial Transplant. 2007; 22: 128-138
12. Girndt M, Sester M, Sester U, et al. Molecular aspects of T-And B-cell function in uremia. Kidney Int Suppl. 2001; 78: S206-S211
13. Meijers RW. T-cell ageing in end-stage renal disease patients: Assessment and clinical relevance. World J Nephrol. 2014; 3: 268-276
14. Fernandez-Fresnedo G, Ramos MA, Gonzalez-Pardo MC, et al. B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2. Nephrol Dial Transplant. 2000; 15: 502-510
15. Bouts AH, Davin JC, Krediet RT, et al. Children with chronic renal failure have reduced numbers of memory B cells. Clin Exp Immunol. 2004; 137: 589-594
16. Vacher-Coponat H, Brunet C, Lyonnet L, et al. Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients. Nephrol Dial Transplant. 2008; 23: 1406-1414
17. Kim KW, Chung BH, Jeon EJ, et al. B cell-Associated immune profiles in patients with end-stage renal disease (ESRD). Exp Mol Med. 2012; 44: 465-472
18. Saad K, Elsayh KI, Zahran AM, Sobhy KM. Lymphocyte populations and apoptosis of peripheral blood B and T lymphocytes in children with end stage renal disease. Ren Fail. 2014; 36: 502-507
19. Borges A, Borges M, Fernandes J, et al. Apoptosis of peripheral CD4(+) T-lymphocytes in end-stage renal disease patients under hemodialysis and rhEPO therapies. Ren Fail. 2011; 33: 138-143
20. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 Suppl 1):S1-S266
21. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150: 604-612
22. Hulstaert F, Hannet I, Deneys V, et al. Age-related changes in human blood lymphocyte subpopulations. II. Varying Kinetics of Percentage and Absolute Count Measurements. Clin Immunol Immunopathol. 1994; 70: 152-158
23. Cicin-Sain L, Messaoudi I, Park B, et al. Dramatic increase in naive T cell turnover is linked to loss of naive T cells from old primates. Proc Natl Acad Sci USA. 2007; 104: 19960-19965
24. Moser B, Roth G, Brunner M, et al. Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: A comparative evaluation between non-dialysis, hemodialysis, and peritoneal dialysis. Biochem Biophys Res Commun. 2003; 308: 581-585
25. Pahl MV, Gollapudi S, Sepassi L, et al. Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression. Nephrol Dial Transplant. 2010; 25: 205-212
26. Vaziri ND, Pahl MV, Crum A, Norris K. Effect of uremia on structure and function of immune system. J Ren Nutr. 2012; 22: 149-156
27. Griveas I, Visvardis G, Fleva A, et al. Comparative analysis of immunophenotypic abnormalities in cellular immunity of uremic patients undergoing either hemodialysis or continuous ambulatory peritoneal dialysis. Ren Fail. 2005; 27: 279-282
28. Meijers RW, Litjens NH, de Wit EA, et al. Uremia causes premature ageing of the T cell compartment in end-stage renal disease patients. Immun Ageing. 2012; 9: 19-26
29. Eleftheriadis T, Antoniadi G, Liakopoulos V, et al. Disturbances of acquired immunity in hemodialysis patients. Semin Dial. 2007; 20: 440-451
30. Hauser AB, Stinghen AE, Kato S, et al. Characteristics and causes of immune dysfunction related to uremia and dialysis. Perit Dial Int. 2008; 28 (Suppl 3): S183-S187
31. Lisowska KA, Debska-Slizien A, Jasiulewicz A, et al. Hemodialysis affects phenotype and proliferation of CD4-positive T lymphocytes. J Clin Immunol. 2012; 32: 189-200
32. Betjes MG, Meijers RW, de Wit LE, Litjens NH. A killer on the road: Circulating CD4(+)CD28null T cells as cardiovascular risk factor in ESRD patients. J Nephrol. 2012; 25: 183-191
33. Hamze M, Desmetz C, Guglielmi P. B cell-derived cytokines in disease. Eur Cytokine Netw. 2013; 24: 20-26
34. Kattah AG, Fervenza FC, Roccatello D. Rituximab-based novel strategies for the treatment of immune-mediated glomerular diseases. Autoimmun Rev. 2013; 12: 854-859
35. Smogorzewski M, Massry SG. Defects in B-cell function and metabolism in uremia: Role of parathyroid hormone. Kidney Int Suppl. 2001; 78: S186-S189
36. Gaciong Z, Alexiewicz JM, Linker-Israeli M, et al. Inhibition of immunoglobulin production by parathyroid hormone. Implications in chronic renal failure. Kidney Int. 1991; 40: 96-106
37. Woitas RP, Stoffel-Wagner B, Poege U, et al. Low-molecular weight proteins as markers for glomerular filtration rate. Clin Chem. 2001; 47: 2179-2180
38. Mojiminiyi OA, Abdella N. Evaluation of cystatin C and beta-2 microglobulin as markers of renal function in patients with type 2 diabetes mellitus. J Diabetes Complications. 2003; 17: 160-168
39. Shinkai S, Chaves PH, Fujiwara Y, et al. Beta2-microglobulin for risk stratification of total mortality in the elderly population: Comparison with cystatin C and C-reactive protein. Arch Intern Med. 2008; 168: 200-206
40. Hoke M, Pernicka E, Niessner A, et al. Renal function and long-Term mortality in patients with asymptomatic carotid atherosclerosis. Thromb Haemost. 2012; 107: 150-157
41. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N, et al. Revisiting mortality predictability of serum albumin in the dialysis population: Time dependency, longitudinal changes and population-Attributable fraction. Nephrol Dial Transplant. 2005; 20: 1880-1888
42. Astor BC, Shafi T, Hoogeveen RC, et al. Novel markers of kidney function as predictors of ESRD, cardiovascular disease, and mortality in the general population. Am J Kidney Dis. 2012; 59: 653-662
43. Schaeffner ES, Kurth T, Curhan GC, et al. Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol. 2003; 14: 2084-2091
44. Chen SC, Hung CC, Kuo MC, et al. Association of dyslipidemia with renal outcomes in chronic kidney disease. PLoS One. 2013; 8: e55643
45. Lodoen MB, Lanier LL. Natural killer cells as an initial defense against pathogens. Curr Opin Immunol. 2006; 18: 391-398
46. Fogel LA, Yokoyama WM, French AR. Natural killer cells in human autoimmune disorders. Arthritis Res Ther. 2013; 15: 216
47. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol. 2001; 22: 633-640
48. Fehniger TA, Cooper MA, Nuovo GJ, et al. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: A potential new link between adaptive and innate immunity. Blood. 2003; 101: 3052-3057
49. Nairn J, Hodge G, Henning P. Intracellular cytokines in peripheral blood leucocytes in children with chronic renal failure. Pediatr Nephrol. 2006; 21: 251-256
50. Eleftheriadis T, Kartsios C, Yiannaki E, et al. Chronic inflammation and CD16+ natural killer cell zeta-chain downregulation in hemodialysis patients. Blood Purif. 2008; 26: 317-321
51. Peraldi MN, Berrou J, Dulphy N, et al. Oxidative stress mediates a reduced expression of the activating receptor NKG2D in NK cells from end-stage renal disease patients. J Immunol. 2009; 182: 1696-1705
52. Hayakawa M, Hatano T, Sunabe T, et al. Cytokine production and cytotoxicity of lymphocytes in patients on maintenance short-or long-Term haemodialysis. Nephrol Dial Transplant. 1994; 9: 655-661
53. Zaza G, Granata S, Rascio F, et al. A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients. BMC Med Genomics. 2013; 6: 17
54. Jurewicz M, McDermott DH, Sechler JM, et al. Human T and natural killer cells possess a functional renin-Angiotensin system: Further mechanisms of angiotensin II-induced inflammation. J Am Soc Nephrol. 2007; 18: 1093-1102
55. Meier P, Dayer E, Blanc E, Wauters JP. Early T cell activation correlates with expression of apoptosis markers in patients with end-stage renal disease. J Am Soc Nephrol. 2002; 13: 204-212
56. Matsumoto Y, Shinzato T, Amano I, et al. Relationship between susceptibility to apoptosis and Fas expression in peripheral blood T cells from uremic patients: A possible mechanism for lymphopenia in chronic renal failure. Biochem Biophys Res Commun. 1995; 215: 98-105
57. Yoon JW, Gollapudi S, Pahl MV, Vaziri ND. Naïve and central memory T-cell lymphopenia in end-stage renal disease. Kidney Int. 2006; 70: 371-376
58. Nitta K, Akiba T, Kawashima A, et al. Characterization of TH1/TH2 profile in uremic patients. Nephron. 2002; 91: 492-495
59. Betjes MG, Litjens NH. Chronic kidney disease and premature ageing of the adaptive immune response. Curr Urol Rep. 2015; 16: 471-476
60. Meijers RW, Betjes MG, Baan CC, Litjens NH. T-cell ageing in end-stage renal disease patients: Assessment and clinical relevance. World J Nephrol. 2014; 3: 268-276
61. Shi YY, Li ZY, Zhao MH, Chen M. The CD4 lymphocyte count is a better predictor of overall infection than the total lymphocyte count in ANCA-Associated vasculitis under a corticosteroid and cyclophosphamide regimen: A retrospective cohort. Medicine (Baltimore). 2015; 94: e843-e852